Motley Fool14d agoneutral
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
73last 24h
976last 7d
109● bullish (7d)
126● bearish (7d)
212publishers
Insider Monkey32d agobullish
Guardant Health (GH) Surges on FDA Approval and Cancer Screening MomentumAristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 14.69% in the second quarter of 2026, slightly trailing the 15.20% gain of the S&P 500 Index as market performance remained highly concentrated in artificial intelligence (AI)-related […]
Insider Monkey37d agoneutral
Loss of Market Share in U.S. Antitrust Consulting Pressures FTI Consulting’s (FCN) Top-Line PerformanceSycamore Capital Management, a franchise of Victory Capital Management, released its Q2 2026 investor letter for “Sycamore Mid Cap Value Equity Strategy”. A copy of the letter can be downloaded here. Sycamore Capital’s Mid Cap Value investment team focuses on a bottom-up approach to identify undervalued businesses with growth potential. In Q2 2026, the strategy […]
Investor's Business Daily67d agobearish
Stock Market Today: Dow Falls Ahead Of CPI Inflation Report; IBM Plunges 23% On Earnings (Live Coverage)Stock Market Today: The Dow Jones index dropped Tuesday ahead of the June CPI inflation report. IBM stock plunged 23% on earnings.
Insider Monkey83d agobullish
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBCGilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]
TheStreet85d agobearish
Tesla faces lawsuit from family of victim killed in Texas home crashTesla investors have placed a lot of eggs in the company's autonomous driving basket to justify its 338x trailing twelve-month price-to-earnings ratio. The S&P 500 currently has a TTMPE ratio of 32, according to Multpl. The company doubled down on its autonomous driving ambitions earlier this ...
Barrons.com93d agobearish
Waymo Has a Tesla-Like Recall. What It Means for Alphabet Stock.Waymo is recalling 3,871 robo-taxis to correct software that might allow a vehicle to enter a freeway construction zone, according to a National Highway Traffic Safety Administration notice. For starters, it illustrates the size of the Waymo robo-taxi fleet. The Alphabet -owned ride-hailing network operator is expanding across the country, along with other companies, including Tesla Amazon.com -backed Zoox, and others.
Motley Fool105d agobearish
Stock Market Today, June 5: Warner Bros. Discovery Falls on Reports of State Antitrust Challenge to Paramount DealShareholder approval moved the deal forward, but antitrust scrutiny now puts the focus on whether regulators seek divestitures or conditions that could affect the timing and economics of the transaction.